<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">FNS</journal-id><journal-title-group><journal-title>Food and Nutrition Sciences</journal-title></journal-title-group><issn pub-type="epub">2157-944X</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/fns.2021.1211075</article-id><article-id pub-id-type="publisher-id">FNS-113152</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Factors Associated with Hypovitaminosis D in People Living with HIV/AIDS (PLWHA) Followed up in Porto-Novo in 2019
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Alassani</surname><given-names>Adébayo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Gninkoun</surname><given-names>Comlan Jules</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mizèhoun-Adissoda</surname><given-names>Carmelle</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Dovonou</surname><given-names>C. Albert</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Attinsounon</surname><given-names>Cossi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Wanvoégbè</surname><given-names>Armand</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib></contrib-group><aff id="aff2"><addr-line>Medicine and Medical Specialties, Faculty of Medicine, University of Abomey-Calavi, Abomey-Calavi, Benin</addr-line></aff><aff id="aff1"><addr-line>Medicine and Medical Specialties, Faculty of Medicine, University of Parakou, Parakou, Benin</addr-line></aff><pub-date pub-type="epub"><day>05</day><month>11</month><year>2021</year></pub-date><volume>12</volume><issue>11</issue><fpage>1020</fpage><lpage>1027</lpage><history><date date-type="received"><day>18,</day>	<month>August</month>	<year>2021</year></date><date date-type="rev-recd"><day>13,</day>	<month>November</month>	<year>2021</year>	</date><date date-type="accepted"><day>16,</day>	<month>November</month>	<year>2021</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  <b>Background:</b>
   Vitamin D deficiency is very common among PLWHA compared to the general population and is promoted by several factors. <b>Aim:</b> To identify the factors associated with hypovitaminosis D in people living with HIV/AIDS (PLWHA) followed up in Porto-Novo in 2019. <b>Methods: </b>This was a cross-sectional, descriptive and analytical study. PLWHA who were monitored on an outpatient basis and who gave their consent were included in this work. Subjects unable to answer questions or under ongoing vitamin D supplementation or suffering from chronic liver diseases were not included. Hypovitaminosis D was defined by a blood level of 25 hydroxy-vitamin D less than 30 ng/mL. <b>Results: </b>A total of 270 PLWHA were included in the study. The mean age of the patients was 39.51 &#177; 6.85 years with a female predominance (73.3%). The frequency of hypovitaminosis D was 56%. Hypertension, low protein intake, anemia and low glomerular filtration rate were associated with vitamin D deficiency. <b>Conclusion:</b> Vitamin D deficiency is common among PLWHA, which justifies routine screening, especially among those at risk.
 
</p></abstract><kwd-group><kwd>Hypovitaminosis D</kwd><kwd> PLWHA</kwd><kwd> Malnutrition</kwd><kwd> Denutrition</kwd><kwd> Porto-Novo</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Since the advent of highly active antiretroviral therapy in 1996, there has been an improvement in the quality of life and prognosis of HIV-infected individuals, as regards the decrease in the frequency of opportunistic diseases. Despite this significant improvement, HIV infection remains a public health problem. In 2018, 1.7 million new infections were recorded worldwide and 1 million deaths were due to HIV infection; the majority of these occur in developing countries [<xref ref-type="bibr" rid="scirp.113152-ref1">1</xref>]. This mortality is multifactorial including not only opportunistic conditions but also metabolic abnormalities such as vitamin D deficiency [<xref ref-type="bibr" rid="scirp.113152-ref2">2</xref>]. Indeed, vitamin D deficiency is very common among PLWHA compared to the general population with a prevalence that varies between 70% and 85% depending on the studies [<xref ref-type="bibr" rid="scirp.113152-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.113152-ref4">4</xref>]. Several factors promote this vitamin deficiency including low exposure to sunlight, low dietary intake of vitamin D, alcohol consumption [<xref ref-type="bibr" rid="scirp.113152-ref3">3</xref>], chronic inflammation caused by the virus and antiretroviral treatment including protease inhibitors and non-nucleoside reverse transcriptase inhibitors [<xref ref-type="bibr" rid="scirp.113152-ref2">2</xref>]. Vitamin D deficiency is associated with high morbidity including bone, cardiovascular, metabolic [<xref ref-type="bibr" rid="scirp.113152-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.113152-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.113152-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.113152-ref8">8</xref>]. Several studies have reported the beneficial effects of a normal vitamin D level in the prevention of opportunistic conditions and thus the reduction of mortality [<xref ref-type="bibr" rid="scirp.113152-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.113152-ref10">10</xref>]. In Africa, studies on vitamin D deficiency in PLWHA are rare and non-existent in Benin. That’s what justifies the present work whose aim is to identify the prevalence of vitamin D deficiency and its contributing factors.</p></sec><sec id="s2"><title>2. Patients and Method</title><p>It was a transversal, descriptive and analytical study that took place from January 2 to February 5, 2019 at the Medical Center (MC) of Oganla in Porto-Novo. The study population consisted of PLWHA followed at this center. Outpatients PLWHA who gave their consent were included in this study. Subjects who were unable to answer questions or under ongoing vitamin D supplementation or who had chronic liver diseases were not included.</p><p>All patients followed up in the center who met the inclusion criteria were considered and it was a sampling by commodity.</p><p>Definition of variables: the dependent variable was hypo-25-hydroxy-vitamin D and the independent variables related to sociodemographic characteristics, lifestyle, history and comorbidities, nutritional status, dietary data and biological data (including hemoglobin, transaminases, creatinine and CD4 levels).</p><p>Hypo 25 hydroxy-vitamin D was defined by a blood level below 30 ng/mL [<xref ref-type="bibr" rid="scirp.113152-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.113152-ref12">12</xref>].</p><p>Physical inactivity was defined for a moderate intensity activity practice such as brisk walking less than 30 minutes.</p><p>Nutritional status was assessed by the body mass index (BMI) and interpreted as follows: underweight if BMI less than 18.5 Kg/m<sup>2</sup>; Normal BMI if between 18.5 and 24.9 Kg/m<sup>2</sup>; overweight if BMI between 25 and 29.9 Kg/m<sup>2</sup>; obesity if BMI greater than or equal to 30 Kg/m<sup>2</sup>.</p><p>The food intake was appreciated by the reminder of the 72 hours and the dietary needs appreciated by the Alimenth&#232;que software; the daily energy intake was normal if it is equal to &#177;200 kcal of the calculated energy needs, the protein intake was considered low if it is less than 15% of the energy needs.</p><p>A daily consumption of fruits and vegetables less than 5 servings was considered low.</p><p>The glomerular filtration rate less than 60 ml/min/m<sup>2</sup> was considered low.</p><p>Data collection techniques: Data collection was done through an individual face-to-face interview followed by clinical examination, anthropometric data measurement, 72-hours recall, and bioassay.</p><p>Data processing and analysis: The data were entered into Epi info 3.5 and analyzed using Statistical Package for Social Sciences (SPSS) version 20.0. The Chi<sup>2</sup> test was calculated. A p-value &lt; 0.05 was considered statistically significant.</p><p>Ethical aspects: the various measures taken before, during and after the collection of the data were the obtaining of an authorization from the administrative officials, the consent of the patients after explaining to them the purpose of the study and the role of vitamin D in the health of the population in general and more specifically in PLWHA and finally the respect of the confidentiality and anonymity of the results obtained.</p></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. General Characteristics of the Study Population</title><p>A total of 270 PLWHA were included in the study. The mean age of the patients was 39.51 &#177; 6.85 years with a female predominance (73.3%).</p><p>History and comorbidities were represented by tuberculosis, high blood pressure and diabetes in 14.4%, 18.9% and 3.3% respectively.</p><p>Lifestyle was characterized by alcohol consumption (58.9%), physical inactivity (55.6%), use of oral contraceptives (16.7%), use of skin creams (27.8%) and the practice of depigmentation (31.1%). Therapeutically, 2.6% of PLWHA were on protease inhibitors and in 97.4% of cases Efavirenz was used (<xref ref-type="table" rid="table1">Table 1</xref>).</p></sec><sec id="s3_2"><title>3.2. Nutritional Status, Food and Biological Data</title><p>Nutritionally 27 patients (10%) were underweight. On the dietary level, a low energy intake was observed in 25.6% of patients and a low protein intake was present in 48.9% and all patients had a low consumption of fruits and vegetables.</p><p>Regarding biological abnormalities, anemia was noted in 45.9% of patients, a low glomerular filtration rate in 24.1% of cases and a CD4 &lt; 200/mm<sup>3</sup> level in 55.6% of cases.</p><p>Among the respondents, 150 had a low vitamin D level, a prevalence of 55.6% with mean value of 27.24 ng/mL and extremes of 2 and 52.97 ng/mL (<xref ref-type="table" rid="table2">Table 2</xref>).</p></sec><sec id="s3_3"><title>3.3. Factors Associated with Hypovitaminosis D</title><p>Factors associated with hypovitaminosis D in multivariate analysis were high blood pressure, anemia, low protein intake and low glomerular filtration rate (<xref ref-type="table" rid="table3">Table 3</xref>).</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> General characteristics of PHA followed in Porto-Novo in 2019 (n = 270)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >n</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle" >age</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;40 years</td><td align="center" valign="middle" >144</td><td align="center" valign="middle" >53.3</td></tr><tr><td align="center" valign="middle" >≥40 years</td><td align="center" valign="middle" >126</td><td align="center" valign="middle" >46.7</td></tr><tr><td align="center" valign="middle" >sex</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Male</td><td align="center" valign="middle" >72</td><td align="center" valign="middle" >26.7</td></tr><tr><td align="center" valign="middle" >Female</td><td align="center" valign="middle" >198</td><td align="center" valign="middle" >73.3</td></tr><tr><td align="center" valign="middle" >complexion</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >tanned</td><td align="center" valign="middle" >96</td><td align="center" valign="middle" >35.6</td></tr><tr><td align="center" valign="middle" >black</td><td align="center" valign="middle" >174</td><td align="center" valign="middle" >64.4</td></tr><tr><td align="center" valign="middle" >History and comorbidities</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >tuberculosis</td><td align="center" valign="middle" >39</td><td align="center" valign="middle" >14.4</td></tr><tr><td align="center" valign="middle" >High blood pressure</td><td align="center" valign="middle" >51</td><td align="center" valign="middle" >18.9</td></tr><tr><td align="center" valign="middle" >diabetes</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >3.3</td></tr><tr><td align="center" valign="middle" >Lifestyle</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >tobacco</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >3.3</td></tr><tr><td align="center" valign="middle" >alcohol</td><td align="center" valign="middle" >159</td><td align="center" valign="middle" >58.9</td></tr><tr><td align="center" valign="middle" >Physical inactivity</td><td align="center" valign="middle" >150</td><td align="center" valign="middle" >55.6</td></tr><tr><td align="center" valign="middle" >Contraceptives</td><td align="center" valign="middle" >33</td><td align="center" valign="middle" >16.7</td></tr><tr><td align="center" valign="middle" >Skin creams</td><td align="center" valign="middle" >75</td><td align="center" valign="middle" >27.8</td></tr><tr><td align="center" valign="middle" >depigmentation</td><td align="center" valign="middle" >84</td><td align="center" valign="middle" >31.1</td></tr><tr><td align="center" valign="middle" >Antiretroviral treatment</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >With protease inhibitors</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >2.6</td></tr><tr><td align="center" valign="middle" >Treatment with Efavirenz</td><td align="center" valign="middle" >263</td><td align="center" valign="middle" >97.4</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Nutritional status, food and biological data of PHA monitored in Porto-Novo in 2019 (n = 270)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >n</th><th align="center" valign="middle" >%</th></tr></thead><tr><td align="center" valign="middle" >Nutritional status</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Underweight</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >10</td></tr><tr><td align="center" valign="middle" >normal</td><td align="center" valign="middle" >123</td><td align="center" valign="middle" >45.6</td></tr><tr><td align="center" valign="middle" >overweight</td><td align="center" valign="middle" >90</td><td align="center" valign="middle" >33.3</td></tr><tr><td align="center" valign="middle" >obesity</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >11.1</td></tr><tr><td align="center" valign="middle" >Food data</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Low energy input</td><td align="center" valign="middle" >69</td><td align="center" valign="middle" >25.6</td></tr><tr><td align="center" valign="middle" >Low protein intake</td><td align="center" valign="middle" >132</td><td align="center" valign="middle" >48.9</td></tr><tr><td align="center" valign="middle" >Insufficient consumption of fruit and vegetables</td><td align="center" valign="middle" >270</td><td align="center" valign="middle" >100</td></tr><tr><td align="center" valign="middle" >Biological data</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >anemia</td><td align="center" valign="middle" >124</td><td align="center" valign="middle" >45.9</td></tr><tr><td align="center" valign="middle" >Hepatic cytolysis</td><td align="center" valign="middle" >57</td><td align="center" valign="middle" >21.1</td></tr><tr><td align="center" valign="middle" >Low glomerular filtration</td><td align="center" valign="middle" >66</td><td align="center" valign="middle" >24.4</td></tr><tr><td align="center" valign="middle" >CD4 &lt; 200/mm<sup>3</sup></td><td align="center" valign="middle" >150</td><td align="center" valign="middle" >55.6</td></tr><tr><td align="center" valign="middle" >Vitamin D deficiency</td><td align="center" valign="middle" >150</td><td align="center" valign="middle" >55.6</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Factors associated with vitamin D deficiency among PHAs followed in Porto-Novo in 2019 (Multivariate analysis)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >gold</th><th align="center" valign="middle" >95% CI</th><th align="center" valign="middle" >p</th></tr></thead><tr><td align="center" valign="middle" >High blood pressure</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.04</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >7.56</td><td align="center" valign="middle" >1.15 - 49.6</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Low protein intake</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.01</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >0.26</td><td align="center" valign="middle" >0.07 - 0.98</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >anemia</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.02</td></tr><tr><td align="center" valign="middle" >Yes</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.03 - 0.70</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >No</td><td align="center" valign="middle" >0.14</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Glomerular filtration rate</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.03</td></tr><tr><td align="center" valign="middle" >low</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >0.11 - 0.70</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >normal</td><td align="center" valign="middle" >0.27</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap></sec></sec><sec id="s4"><title>4. Discussion</title><p>The present study, which aimed at studying vitamin D deficiency in PLWHA, is one of the few conducted in Benin. At the end of this study, it appears that the prevalence of vitamin D deficiency in this population was 56% and that the factors associated with it were high blood pressure, anemia, low protein intake and low glomerular filtration rate...</p><p>The high prevalence of vitamin D deficiency found in our work is similar to that reported by Arnedo-Pena (45.1%) [<xref ref-type="bibr" rid="scirp.113152-ref13">13</xref>]. In the general population, the prevalence of vitamin D deficiency is lower; in the study of Tangoh et al. [<xref ref-type="bibr" rid="scirp.113152-ref14">14</xref>] in Cameroon, and was 3.2%. In USA, Pasquale M. et al. has reported a high prevalence of hypovitaminosis D among HIV-infected subjects ranging from 70.3 to 83.7% [<xref ref-type="bibr" rid="scirp.113152-ref15">15</xref>].</p><p>The factors associated with vitamin D deficiency in the present study were similar to those found in the literature. Indeed, Magurno [<xref ref-type="bibr" rid="scirp.113152-ref16">16</xref>] and Fondio [<xref ref-type="bibr" rid="scirp.113152-ref17">17</xref>] respectively reported in their studies that high blood pressure was associated with vitamin D deficiency. The association between cardiovascular diseases and vitamin D deficiency has been explained by some authors. Indeed, In HIV-infected subjects atherogenesis is enhanced by several factors: HIV-induced chronic inflammation and immune activation (demonstrated by increased levels of proinflammatory cytokines and endothelial activation markers), excess of traditional risk factors, and antiretroviral drug-related dyslipidemia, hyperglycemia, central obesity, and lipodystrophy [<xref ref-type="bibr" rid="scirp.113152-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.113152-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.113152-ref20">20</xref>]. Vitamin D influences cardiovascular health by suppressing the renin-angiotensin system and stimulating cellular proliferation and differentiation via 1,25(OH)2D binding to vitamin D receptors in the heart, the endothelium, and the vascular smooth muscle [<xref ref-type="bibr" rid="scirp.113152-ref21">21</xref>] [<xref ref-type="bibr" rid="scirp.113152-ref22">22</xref>].</p><p>In addition, subjects with anemia were at increased risk of vitamin D deficiency according to Kumari et al. [<xref ref-type="bibr" rid="scirp.113152-ref23">23</xref>] and Mehta S et al. [<xref ref-type="bibr" rid="scirp.113152-ref24">24</xref>].</p><p>A low-protein diet associated with vitamin D deficiency was noted by Parva et al. [<xref ref-type="bibr" rid="scirp.113152-ref25">25</xref>]. Indeed, this low protein intake can promote undernutrition which is recognized as a factor associated with vitamin D deficiency [<xref ref-type="bibr" rid="scirp.113152-ref26">26</xref>] [<xref ref-type="bibr" rid="scirp.113152-ref27">27</xref>]. The association between decreased glomerular filtration rate i.e. renal failure and vitamin D deficiency was reported by Ali [<xref ref-type="bibr" rid="scirp.113152-ref28">28</xref>] and Singh [<xref ref-type="bibr" rid="scirp.113152-ref29">29</xref>]. This would be due at least in part, to the renal synthesis defect of 1α hydroxylase necessary for vitamin D metabolism. Moreover, chronic inflammation due to HIV infection and subsequent TNF-α overproduction may be responsible for renal 1α-hydroxylase impairment, reducing the PTH (parathyroid hormone) stimulatory effect on the production of the hormonally active 1,25(OH)2D (1,25-dihydroxyvitamin D) [<xref ref-type="bibr" rid="scirp.113152-ref15">15</xref>].</p><p>However, these findings are limited by the use of a cross sectional design.</p></sec><sec id="s5"><title>5. Conclusion</title><p>Vitamin D deficiency is very common among PLWHA. The identified risk factors were high blood pressure, anemia, low protein intake and low glomerular filtration rate. Systematic screening for vitamin D deficiency should be done especially among those at risk to provide adequate care. A future study may assess the impact of vitamin D supplementation on the morbi-mortality of PLWHA with deficiency.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Ad&#233;bayo, A., Jules, G.C., Carmelle, M.-A., Albert, D.C., Cossi, A. and Armand, W. (2021) Factors Associated with Hypovitaminosis D in People Living with HIV/AIDS (PLWHA) Followed up in Porto-Novo in 2019. Food and Nutrition Sciences, 12, 1020-1027. https://doi.org/10.4236/fns.2021.1211075</p></sec></body><back><ref-list><title>References</title><ref id="scirp.113152-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">UNAIDS Data 2019 (2019) Jt United Nations Program HIV/AIDS. Geneva, 468 p. https://www.unaids.org/sites/default/files/media_asset/2019-UNAIDS-data_en.pdf</mixed-citation></ref><ref id="scirp.113152-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Alvarez, N., Aguilar-Jimenez, W. and Rugeles, M.T. (2019) The Potential Protective Role of Vitamin D Supplementation on HIV-1 Infection. Frontiers in Immunology, 10, Article No. 2291. https://doi.org/10.3389/fimmu.2019.02291</mixed-citation></ref><ref id="scirp.113152-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Jiménez-Sousa, M.á., Martínez, I., Medrano, L.M., Fernández-Rodríguez, A. and Resino, S. (2018) Vitamin D in Human Immunodeficiency Virus Infection: Influence on Immunity and Disease. Frontiers in Immunology, 9, Article No. 458. https://doi.org/10.3389/fimmu.2018.00458</mixed-citation></ref><ref id="scirp.113152-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Ncayiyana, J.R., Martinez, L., Goddard, E., Myer, L. and Zar, H.J. (2021) Prevalence and Correlates of Vitamin D Deficiency among Young South African Infants: A Birth Cohort Study. Nutrients, 13, Article ID: 1500. https://doi.org/10.3390/nu13051500</mixed-citation></ref><ref id="scirp.113152-ref5"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>D’Amelio</surname><given-names> P. </given-names></name>,<etal>et al</etal>. (<year>2021</year>)<article-title>Vitamin D Deficiency and Risk of Metabolic Syndrome in Aging Men</article-title><source> The World Journal of Men’s Health</source><volume> 39</volume>,<fpage> 291</fpage>-<lpage>301</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.113152-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Aibana, O., Huang, C.C., Aboud, S., Arnedo-Pena, A., Becerra, M.C., Bellido-Blasco, J.B., et al. (2019) Vitamin D Status and Risk of Incident Tuberculosis Disease: A Nested Case-Control Study, Systematic Review, and Individual-Participant Data Meta-Analysis. PLoS Medicine, 16, e1002907. https://doi.org/10.1371/journal.pmed.1002907</mixed-citation></ref><ref id="scirp.113152-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Tenforde, W., Yadav, A. and Dowdy, W. (2017) Vitamin A and D Deficiencies Associated with Incident Tuberculosis in HIV-Infected Patients Initiating Antiretroviral Therapy in Multinational Case-Cohort Study. Journal of Acquired Immune Deficiency Syndromes, 75, e71-e79. https://doi.org/10.1097/QAI.0000000000001308</mixed-citation></ref><ref id="scirp.113152-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Manion, M., Hullsiek, K.H., Wilson, E.M.P., Rhame, F., Kojic, E., Gibson, D., et al. (2017) Vitamin D Deficiency Is Associated with IL-6 Levels and Monocyte Activation in HIV-Infected Persons. PLoS ONE, 12, e0175517.</mixed-citation></ref><ref id="scirp.113152-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Lee, J., Kim, J.Y., Kim, J., Mun, J.W. and Yeo, J.Y. (2021) Prevalence of and Risk Factors for Hypovitaminosis D in Patients with Rotator Cuff Tears. Clinics in Orthopedic Surgery, 13, 237-242.</mixed-citation></ref><ref id="scirp.113152-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Caccamo, D., Ricca, S., Currò, M. and Lentile, R. (2018) Health Risks of Hypovitaminosis D: A Review of New Molecular Insights. International Journal of Molecular Sciences, 19, Article No. 892. https://doi.org/10.3390/ijms19030892</mixed-citation></ref><ref id="scirp.113152-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Alzahed, R.A. (2018) The Prevalence of Hypovitaminosis D and Its Associated Risk Factors among Women of Reproductive Age in Saudi Arabia: A Systematic Review and Meta-Analysis. Clinical Medicine Insights: Women’s Health, 11, 1-9.https://doi.org/10.1177/1179562X18767884</mixed-citation></ref><ref id="scirp.113152-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Hussain, S. and Elnajeh, M. (2020) Prevalence and Risk Factors for Hypovitaminosis D among Healthy Adolescents in Kota Bharu, Kelantan. Journal of the ASEAN Federation of Endocrine Societies, 35, 176-180.</mixed-citation></ref><ref id="scirp.113152-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Arnedo-Pena, A., Juan-Cerda, J.V., Romeu-Garcia, M., Sorribes-Segura, S., Tirado-Balaguer, M., Gil-Fortun, M., et al. (2020) Vitamin D Status and Latent Tuberculosis Infection: Conversion in Nursing Homes, Spain. The International Journal of Tuberculosis and Lung Disease, 24, 278-286. https://doi.org/10.5588/ijtld.19.0365</mixed-citation></ref><ref id="scirp.113152-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Tangoh, D.A., Apinjoh, T.O., Mahmood, Y., Nyingchu, R.V., Tangunyi, B.A., Nji, E.N., et al. (2018) Vitamin D Status and Its Associated Risk Factors among Adults in the Southwest Region of Cameroon. Journal of Nutrition and Metabolism, 2018, Article ID: 4742574. https://doi.org/10.1155/2018/4742574</mixed-citation></ref><ref id="scirp.113152-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Mansueto, P., Seidita, A., Vitale, G., Gangemi, S., Iaria, C. and Cascio, A. (2015) Vitamin D Deficiency in HIV Infection: Not Only a Bone Disorder. BioMed Research International, 2015, Article ID: 735615. https://doi.org/10.1155/2015/735615</mixed-citation></ref><ref id="scirp.113152-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Magurno, M., Crescibene, D., Spinali, M., Cassano, V., Armentaro, G., Barbara, K., et al. (2021) Vitamin D and Subclinical Cardiovascular Damage in Essential Hypertension. Endocrines, 2, 133-141. https://doi.org/10.3390/endocrines2020013</mixed-citation></ref><ref id="scirp.113152-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Fondjo, L.A., Tashie, W., Owiredu, W.K., Adu-Gyamfi, E.A. and Seidu, L. (2021) High Prevalence of Vitamin D Deficiency among Normotensive and Hypertensive Pregnant Women in Ghana. BMC Pregnancy and Childbirth, 21, Article No. 331. https://doi.org/10.1186/s12884-021-03802-9</mixed-citation></ref><ref id="scirp.113152-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Crowe, S.M., Westhorpe, C.L.V., Mukhamedova, N., Jaworowski, A., Sviridov, D. and Bukrinsky, M. (2010) The Macrophage: The Intersection between HIV Infection and Atherosclerosis. Journal of Leukocyte Biology, 87, 589-598. https://doi.org/10.1189/jlb.0809580</mixed-citation></ref><ref id="scirp.113152-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Friis-Moller, N., Weber, R., Reiss, P., Thiebaut, R., Kirk, O. and d’Arminio Monforte, A. (2003) Cardiovascular Disease Risk Factors in HIV Patients—Association with Antiretroviral Therapy. Results from the DAD Study. AIDS, 17, 1179-1193. https://doi.org/10.1097/00002030-200305230-00010</mixed-citation></ref><ref id="scirp.113152-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Galli, M., Ridolfo, A.L., Adorni, F., et al. (2002) Body Habitus Changes and Metabolic Alterations in Protease Inhibitor-Naive HIV-1-Infected Patients Treated with Two Nucleoside Reverse Transcriptase Inhibitors. Journal of Acquired Immune Deficiency Syndromes, 29, 21-31. https://doi.org/10.1097/00042560-200201010-00003</mixed-citation></ref><ref id="scirp.113152-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Santoro, D., Gagliostro, G., Alibrandi, A., et al. (2014) Vitamin D Receptor Gene Polymorphism and Left Ventricular Hypertrophy in Chronic Kidney Disease. Nutrients, 6, 1029-1037. https://doi.org/10.3390/nu6031029</mixed-citation></ref><ref id="scirp.113152-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Vaidya, A. and Williams, J.S. (2012) The Relationship between Vitamin D and the Renin-Angiotensin System in the Pathophysiology of Hypertension, Kidney Disease, and Diabetes. Metabolism: Clinical and Experimental, 61, 450-458. https://doi.org/10.1016/j.metabol.2011.09.007</mixed-citation></ref><ref id="scirp.113152-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Kumari, S., Swetha, P., Krishnan, R.S., et al. (2021) The Association between Ferritin and Vitamin D Levels in Premenopausal Fibroid Uterus Cases with Anemia. Cureus, 13, e13392. https://doi.org/10.7759/cureus.13392</mixed-citation></ref><ref id="scirp.113152-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Mehta, S., Mugusi, F.M., Spiegelman, D., et al. (2011) Vitamin D Status and Its Association with Morbidity including Wasting and Opportunistic Illnesses in HIV-Infected Women in Tanzania. AIDS Patient Care and STDs, 25, 579-585. https://doi.org/10.1089/apc.2011.0182</mixed-citation></ref><ref id="scirp.113152-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Parva, N.R., Tadepalli, S., Singh, P., et al. (2018) Prevalence of Vitamin D Deficiency and Associated Risk Factors in the US Population (2011-2012). Cureus, 10, e2741. https://doi.org/10.7759/cureus.2741</mixed-citation></ref><ref id="scirp.113152-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Mendoza-Garcés, L., Velázquez-Alva, M.C., Cabrer-Rosales, M.F., Arrieta-Cruz, I., Gutiérrez-Juárez, R. and Irigoyen-Camacho, M.E. (2021) Vitamin D Deficiency Is Associated with Handgrip Strength, Nutritional Status and T2DM in Community-Dwelling Older Mexican Women: A Cross-Sectional Study. Nutrients, 13, Article No. 736. https://doi.org/10.3390/nu13030736</mixed-citation></ref><ref id="scirp.113152-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Mokhtar, R., Holick, M., Sempértegui, F., Griffiths, J.K., Estrella, B., Moore, L., et al. (2017) Vitamin D Status Is Associated with Underweight and Stunting in Children Aged 6-36 Months Residing in the Ecuadorian Andes. Public Health Nutrition, 21, 1974-1985. https://doi.org/10.1017/S1368980017002816</mixed-citation></ref><ref id="scirp.113152-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Ali, M., Ejaz, A., Solangi, S.A., et al. (2020) Vitamin D Deficiency in End Stage Renal Disease Patients with Diabetes Mellitus Undergoing Hemodialysis. Cureus, 12, e11668. https://doi.org/10.7759/cureus.11668</mixed-citation></ref><ref id="scirp.113152-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Singh, A.K., Maurya, M.K., Baiswar, R. and Kumar, P. (2020) To Study Vitamin-D Insufficiency and Deficiency in Patients of Chronic Kidney Disease. Journal of Medical Science and Clinical Research, 8, 60-64. https://doi.org/10.18535/jmscr/v8i10.09</mixed-citation></ref></ref-list></back></article>